Encapsulation of lipophilic kiteplatin Pt(iv) prodrugs in PLGA-PEG micelles
- 4 April 2016
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 45 (33) , 13070-13081
Abstract
Biodegradable, PEG-coated, nanoparticles (NPs) have gained therapeutic application as injectable colloidal systems for the controlled and site-specific release of drugs. In this paper, encapsulation in PLGA-PEG polymer NPs has been exploited to lower the toxicity and to increase the antitumor activity of kiteplatin ([PtCl2(cis-1,4-DACH)]). Kiteplatin contains an isomeric form of the diamine ligand present in oxaliplatin and proved to be particularly active against ovarian and colon cancers. To favor encapsulation of the platinum drug in the hydrophobic core of the polymeric micelles, Pt(IV) prodrugs having hydrophobic carboxylic ligands at the axial positions were used in place of hydrophilic Pt(II) complexes (compounds 1–4). The size, size distribution, and zeta potential (ZP) were measured by dynamic light scattering (DLS) and laser Doppler velocimetry (LDV), and drug encapsulation efficiency (EE) correlated to the alkyl chain length of the different Pt(IV) prodrugs. The number of the Pt atoms per NP (in the range of 1.3–2.4 × 106) is comparable to that of polysilsesquioxane-based NPs and higher than that found for other nanoparticle platforms. The platinum-loaded PLGA-PEG NPs, tested in vivo in a syngeneic murine solid tumor (LLC), had a higher antitumor effect and, most importantly, were markedly less toxic than kiteplatin.Keywords
This publication has 59 references indexed in Scilit:
- NMR Investigation of the Spontaneous Thermal- and/or Photoinduced Reduction of trans Dihydroxido Pt(IV) DerivativesInorganic Chemistry, 2013
- Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapyProceedings of the National Academy of Sciences, 2010
- Synthesis and Evaluation of Multivalent Branched HPMA Copolymer−Fab′ Conjugates Targeted to the B-Cell Antigen CD20Bioconjugate Chemistry, 2008
- Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticlesProceedings of the National Academy of Sciences, 2008
- Targeted Single-Wall Carbon Nanotube-Mediated Pt(IV) Prodrug Delivery Using Folate as a Homing DeviceJournal of the American Chemical Society, 2008
- Conjugated Platinum(IV)−Peptide Complexes for Targeting Angiogenic Tumor VasculatureBioconjugate Chemistry, 2007
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Soluble Single-Walled Carbon Nanotubes as Longboat Delivery Systems for Platinum(IV) Anticancer Drug DesignJournal of the American Chemical Society, 2007
- Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug deliveryBiomaterials, 2007
- Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticlesLife Sciences, 1997